Cemiplimab
S1800E
Phase 3 mab active
Quick answer
Cemiplimab for Recurrent Lung Non-Small Cell Carcinoma is a Phase 3 program (mab) at REGENERON PHARMACEUTICALS, INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- REGENERON PHARMACEUTICALS, INC.
- Indication
- Recurrent Lung Non-Small Cell Carcinoma
- Phase
- Phase 3
- Modality
- mab
- Status
- active